Pure Global AI
ANVISA registration 10287411601Valid until Jun 13, 2032

SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS)

ANVISA Registration Number: 10287411601ROCHE DIAGNÓSTICA BRASIL LTDASD BIOSENSORRisk Class III
Device names
Technical name
SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS)
PT: AUTOTESTE PARA ANTÍGENO DO SARS-COV-2 (CORONAVÍRUS)
Commercial name
SARS-CoV-2 Antigen Self Test Nasal
Risk class
Class III
Registration details
Registration Number
10287411601
Process Number
25351054892202223
CNPJ
30280358000186
Company information
Manufacturer
SD BIOSENSOR
Manufacturing Country
South Korea
PT: CORÉIA DO SUL
Dates and status
Publication Date
Jun 13, 2022
Validity
13/06/2032
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411601 and manufactured by SD BIOSENSOR. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Jun 13, 2032.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.